Everolimus and Pasireotide for Advanced and Metastatic Hepatocellular Carcinoma

Por Sanoff, Hanna K., Kim, Richard, Ivanova, Anastasia, Alistar, Angela, McRee, Autumn J., O'Neil, Bert H.
Publicado no Invest New Drugs (2015)

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors

Por McRee, Autumn J., Davies, Janine M., Sanoff, Hanna G., Goldberg, Richard M., Bernard, Stephen, Dees, E. Claire, Keller, Kimberly, Ivanova, Anastasia, O'Neil, Bert H.
Publicado no Cancer Chemother Pharmacol (2014)

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss

Por Sendor, Adam B, Hacker, Kathryn E, Chen, Shufen, Corona, Armando L, Sen, Oishee, Chiang, Derek Y, Snavely, Anna, Rogers, Arlin B, Montgomery, Stephanie A, Rathmell, W Kimryn, McRee, Autumn J
Publicado no Gastrointest Cancer (2015)